Treatment and Prevention of Multidrug-Resistant Tuberculosis

Author： Bastian I.   Colebunders R.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.58, Iss.4, 1999-10, pp. : 633-661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis

By Fitzpatrick Christopher   Floyd Katherine  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 63-80

Adis International

Access to resources Recommend Favorite

Treatment Options for Multidrug-Resistant Acinetobacter Species

By Gilad Jacob  

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 165-189

Adis International

Access to resources Recommend Favorite

Linezolid was effective in the treatment of a case of multidrug-resistant tuberculotic spondylitis

By  

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens

By Jean Shio-Shin   Hsueh Po-Ren  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2145-2148

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

By Alffenaar Jan-Willem C.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite